Rithm Capital enters its third-quarter report with an awkward contrast. Management spent the last call describing a company finally hitting its stride, with nearly every division showing better numbers. Yet the stock has fallen about 10.6% since then, trailing the S&P 500 by nearly 15 percentage points. The gap suggests the market cares less about segment momentum than about the figure that sits beneath it all: core earnings per share, which have been drifting quietly lower.
Wall Street expects earnings of $0.50 a share on revenue of roughly $1.49 billion. That revenue figure would mark growth of nearly 35% from a year ago and a sizable step up from the prior quarter's $1.28 billion. The per-share estimate, however, implies a 7.4% decline from the $0.54 earned in the year-ago period and a sharp drop from last quarter's reported $0.60. That last comparison is misleading. The second-quarter number was lifted by an off-cycle Sculptor incentive fee, and stripping it out left a run rate of about $0.50, below the $0.51 of the first quarter. Consensus, in other words, simply assumes the underlying trend holds. With no formal guidance on the table, the real test is whether that $0.50 is a floor or another step on a gentle downward slope.
The operating story gives reasons for optimism. The mortgage arm, Newrez, grew pre-tax income ex-marks by 12% sequentially to $308 million, with return on equity climbing to 22%. Co-issue servicing acquisitions jumped 45%, direct-to-consumer and wholesale channels reached 40% of originations, and third-party servicing boarded $27 billion from eight new clients. Management deliberately cut daily origination to roughly $200 to $250 million from $350 to $400 million, arguing servicing rights were too richly valued and gain-on-sale margins too thin. That restraint makes sense, but it also caps growth. A quarter in which servicing income and recapture offset softer volume would validate the strategy; continued margin pressure alongside flat volume would challenge it, especially in a higher-for-longer rate backdrop that helps the $865 billion servicing book but squeezes lending.
Beyond mortgages, several promises now come due. The 1301 Sixth Avenue joint venture moved to a signed letter of intent last quarter with a close expected by the end of the third quarter, so this report should confirm whether that deal crossed the line. Elicor's San Francisco occupancy rose to 64.9% and New York initial rents on 2026 leases ran 32% above 2025 levels; further gains would support the thesis that amenity upgrades at four flagship buildings are paying off. Genesis earned about $42 million pre-tax, up 26%, and management talked openly about doubling third-party assets under management from around $60 billion over two years. Evidence of net inflows, not just performance, would make that target feel credible. Valen's cost savings, now framed as a 21% reduction in cost per loan, should also show up in expenses.
Sentiment has warmed modestly from deeply bearish heading into last quarter to slightly positive now, yet the share price tells a gloomier story. At $8.35, the stock sits just above its post-earnings low of $8.31, below last quarter's trough of $8.91 and well under its 200-day moving average near $9.86. It also trades at a steep discount to book value of $12.33, a figure that has slipped for several straight quarters. Management has ruled out buybacks and a dividend increase despite earnings covering the payout, a stance that has done little to narrow that discount.
The central question is whether broad operating momentum can finally translate into steadier per-share results. If core earnings hold at or above $0.50 and book value stops eroding, the recent selloff looks overdone relative to what the businesses are producing. If earnings slip again or hedge marks chip further at book, the market will likely conclude that segment growth is not reaching shareholders, regardless of how confident the tone on the call sounds.